Travere Therapeutics, Inc.

TVTX Net selling

CIK 0001438533 #1223 in the set updated 22 Sep 2026

Bought (120 mo)

$89.25K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$129.25M

$14.01M on a plan · $99.79M straight out of an exercise

Sold at will

$15.45M

267 of 431 sales

Net

−$129.16M

−$15.36M against sales at will

By person

21 insiders · 433 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Dube Eric M

CHIEF EXECUTIVE OFFICER

—

$46.63M (53) scheduled

−$46.63M

432,886

0.4592%

$28.12M

—

Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

—

$19.90M (35) scheduled

−$19.90M

117,066

0.1242%

$7.60M

+865.6%

ROTE WILLIAM E.

Chief Research Officer

—

$18.35M (59) scheduled

−$18.35M

98,197

0.1042%

$6.38M

+826.3%

REED ELIZABETH E

Chief Legal Officer and GC

—

$9.27M (70) scheduled

−$9.27M

105,389

0.1118%

$6.85M

+6,088%

ASELAGE STEVE

Director

$89.25K (1)

$7.30M (40) scheduled

−$7.21M

166,419

0.1766%

$10.81M

−50.4%

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

—

$6.30M (30) scheduled

−$6.30M

42,353

0.0449%

$2.75M

+40.5%

Inrig Jula

EVP, Head of R&D & CMO

—

$5.51M (28) scheduled

−$5.51M

100,491

0.1066%

$6.53M

—

Cline Christopher R.

CHIEF FINANCIAL OFFICER

—

$4.96M (32) scheduled

−$4.96M

87,508

0.0928%

$5.68M

+204.7%

Baynes Roy D.

Director

—

$3.09M (8) scheduled

−$3.09M

41,500

0.0440%

$2.70M

+937.5%

Meckler Jeffrey A

Director

—

$2.27M (6) scheduled

−$2.27M

91,500

0.0971%

$5.94M

+69.4%

Clague Laura

Chief Financial Officer

—

$1.93M (35)

−$1.93M

35,655

0.0378%

$2.32M

—

LYONS GARY A

Director

—

$1.55M (8) scheduled

−$1.55M

61,500

0.0652%

$3.99M

+156.3%

Coughlin Timothy

Director

—

$1.27M (3) scheduled

−$1.27M

56,250

0.0597%

$3.65M

+155.7%

McFarlane Neil F.

Chief Operating Officer

—

$552.56K (7)

−$552.56K

26,988

0.0286%

$1.75M

+56.1%

Rosenberg Noah L.

Chief Medical Officer

—

$366.78K (17)

−$366.78K

47,614

0.0505%

$3.09M

+2,185%

Squarer Ron

Director

—

—

—

39,375

0.0418%

$2.56M

—

Orwin John A

Director

—

—

—

39,375

0.0418%

$2.56M

—

Poole Sandra

Director

—

—

—

34,000

0.0361%

$2.21M

—

Bruhn Suzanne Louise

Director

—

—

—

32,750

0.0347%

$2.13M

—

Williams Brinkley Ruth

Director

—

—

—

29,750

0.0316%

$1.93M

—

KOZARICH JOHN W

Director

—

—

—

29,000

0.0308%

$1.88M

+31.8%

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 423

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 67

Sales straight out of an exercise 97

Sales at will 267

Transactions with no price 0

Shares from compensation/vesting 4,655,938

Sales filed before the plan box existed 219

History held since 2 Sep 2016